Sign In
21 Jan 2016 10:14
21 January 2016
Collagen Solutions Plc
(the "Company" or the "Group")
Ā
Chairman's Share Purchase
Ā
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that David Evans, Chairman of the Company, has today purchased 1,000,000 ordinary shares in the Company at 7.5 pence per share.
Ā
Following this transaction, David Evans total beneficial holding has increased to 13,888,730 ordinary shares representing 8.1 per cent of the issued ordinary share capital of the Company.
Ā
David Evans, Non-Executive Chairman, commented: "As was announced in the recent trading update, I have purchased a further one million shares in Collagen Solutions which re-affirms my commitment to the Company and strong belief in the growth potential that the Company offers."
Ā
Ā
Enquiries:
Ā
Collagen Solutions Plc | ||
David Evans, Chairman | Tel: 07740 084 452 | |
Stewart White, CEO | Tel: 07795 504 465 | |
Panmure Gordon & Co | ||
Robert Naylor (Corporate Finance) Maisie Atkinson (Corporate Broking) | Tel: 020 7886 2714Tel: 020 7886 2905 | |
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com | |
Mike Wort | Mob: 07900 608 002 | |
Anna Dunphy | Mob: 07876 741 001 | |
Ā
Ā
Follow the stocks
